专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2006052222A2 MULTI-FUNCTIONAL COPOLYMERS COMPRISING RARE EARTH METAL COMPLEXES AND DEVICES THEREOF 审中-公开
标题翻译：包含稀土金属复合物的多官能共聚物及其设备
公开(公告)号：WO2006052222A2
公开(公告)日：2006-05-18
申请号：PCT/SG2005000384
申请日：2005-11-10
申请人： UNIV SINGAPORE , LING QIDAN , HUANG WEI , KANG EN-TANG , NEOH KOON GEE
发明人： LING QIDAN , HUANG WEI , KANG EN-TANG , NEOH KOON GEE
CPC分类号： H05B33/14 , C07F5/003 , C08G61/02 , C08G61/12 , C08G61/123 , C08G61/124 , C08G73/026 , C09K11/06 , C09K2211/1416 , C09K2211/182 , H01L51/0043 , H01L51/0089 , H01L51/5012
摘要： The invention relates to copolymer complexes of the formula (I): wherein [A x -[B(C) y -D Z ] denotes a single unit of the copolymer complex that is repeated n times, wherein n is an integer greater than one, and wherein the single unit comprises a conjugated backbone coordinated to a complex (C) comprising rare earth metal(s); x, y and z are numbers greater than zero such that x = y+z ; A is independently selected from a group consisting of: fluorene, carbazole, oxadiazole, triphenylamine or derivatives thereof; B is a functional ligand selected from the group consisting of: benzoic acid, 1,3-diphenylpropane-1,3-dione, 1,10- phenanthroline, 2,2-bipyridine, or derivatives thereof; and D is independently selected from a group consisting of: fluorene, carbazole, oxadiazole, triphenylamine or derivatives thereof.
摘要翻译：本发明涉及式（I）的共聚物络合物：其中[A x X - - [B（C） - Y - Z - ]表示重复n次共聚物复合物的单一单位，其中n是大于1的整数，并且其中单个单元包含与包含稀土金属的络合物（C）配位的共轭骨架; x，y和z是大于零的数字，使得x = y + z; A独立地选自：芴，咔唑，恶二唑，三苯胺或其衍生物; B是选自：苯甲酸，1,3-二苯基丙烷-1,3-二酮，1,10-菲咯啉，2,2-联吡啶或其衍生物的官能配体; D独立地选自：芴，咔唑，恶二唑，三苯胺或其衍生物。

2. 发明申请

WO2006133266A3 METHODS FOR DETERMINING RESISTANCE OR SUSCEPTIBILITY TO HIV ENTRY INHIBITORS 审中-公开
标题翻译：确定对HIV入侵抑制剂的抗性或易感性的方法
公开(公告)号：WO2006133266A3
公开(公告)日：2007-05-18
申请号：PCT/US2006022071
申请日：2006-06-06
申请人： MONOGRAM BIOSCIENCES INC , HUANG WEI
发明人： HUANG WEI
IPC分类号： C12Q1/68 , C12Q1/70
CPC分类号： C12Q1/703 , C12Q2600/156 , C12Q2600/158
摘要： The invention provides a method for determining whether a human immunodeficiency virus is likely to be more resistant to a viral entry inhibitor than a reference HIV. In certain aspects, the methods comprise comparing the length of one or more variable regions of an envelope protein of the HIV or a number of glycosylation sites on the envelope protein of the HIV to a length of one or more corresponding variable regions of an envelope protein of the reference HIV or a number of glycosylation sites on the envelope protein of the reference HIV, wherein the HIV is likely to be more resistant to the CD4 binding site entry inhibitor than the reference HIV when the HIV has longer variable regions than the reference HIV or the HIV has more glycosylation sites than the reference HIV.
摘要翻译：本发明提供了确定人类免疫缺陷病毒是否可能比参考HIV对病毒进入抑制剂更具抗性的方法。在某些方面，所述方法包括比较HIV的包膜蛋白的一个或多个可变区的长度或HIV的包膜蛋白上的多个糖基化位点的长度与包膜蛋白的一个或多个相应可变区的长度的参考HIV或参考HIV的包膜蛋白上的多个糖基化位点，其中当HIV具有比参考HIV更长的可变区时，HIV可能比参考HIV更耐受CD4结合位点进入抑制剂或者HIV比参考HIV具有更多的糖基化位点。

3. 发明申请

WO2008106115A3 COMPOSITIONS AND METHODS FOR DETERMINING WHETHER A SUBJECT WOULD BENEFIT FROM CO-RECEPTOR INHIBITOR THERAPY 审中-公开
标题翻译：用于确定受试者不会受益于受体抑制剂治疗的组合物和方法
公开(公告)号：WO2008106115A3
公开(公告)日：2008-11-27
申请号：PCT/US2008002497
申请日：2008-02-26
申请人： MONOGRAM BIOSCIENCES INC , HUANG WEI , FRANSON SIGNE , PETROPOULOS CHRISTOS J , TOMA JONATHAN , WHITCOMB JEANNETTE
发明人： HUANG WEI , FRANSON SIGNE , PETROPOULOS CHRISTOS J , TOMA JONATHAN , WHITCOMB JEANNETTE
IPC分类号： C12Q1/70 , A61K39/395 , G01N33/566
CPC分类号： C12Q1/703 , C12Q2600/106 , C12Q2600/156 , C12Q2600/158 , G01N33/56988 , G01N2333/16 , G01N2333/162 , G01N2800/52
摘要： The present invention provides methods and compositions for determining whether a subject would benefit from co-receptor inhibitor therapy. In certain aspects, the methods can be used to determine whether a subject infected with a dual -mixed tropic population of HIV would benefit from CCCR5 -inhibitor therapy or CXCR4-inhibitor therapy, the methods comprising determining whether the HIV population is a homogeneous or heterogeneous population of HIV, wherein the nature of the homogenous or heterogenous population of HIV indicates whether the patient would benefit from co-receptor inhibitor therapy.
摘要翻译：本发明提供了用于确定受试者是否将受益于共受体抑制剂治疗的方法和组合物。在某些方面，所述方法可用于确定感染HIV的双重混合热带人群的受试者是否将受益于CCCR5抑制剂治疗或CXCR4抑制剂治疗，所述方法包括确定HIV群体是否是均质的或异质性的艾滋病毒的人群，其中艾滋病的同源或异质群体的性质表明患者是否可以从共同受体抑制剂治疗中受益。

4. 发明申请

WO2006133266A9 METHODS FOR DETERMINING RESISTANCE OR SUSCEPTIBILITY TO HIV ENTRY INHIBITORS 审中-公开
标题翻译：用于确定艾滋病毒入侵抑制剂耐药性或易感性的方法
公开(公告)号：WO2006133266A9
公开(公告)日：2007-04-12
申请号：PCT/US2006022071
申请日：2006-06-06
申请人： MONOGRAM BIOSCIENCES INC , HUANG WEI
发明人： HUANG WEI
IPC分类号： C12Q1/68 , C12Q1/70
CPC分类号： C12Q1/703 , C12Q2600/156 , C12Q2600/158
摘要： The invention provides a method for determining whether a human immunodeficiency virus is likely to be more resistant to a viral entry inhibitor than a reference HIV. In certain aspects, the methods comprise comparing the length of one or more variable regions of an envelope protein of the HIV or a number of glycosylation sites on the envelope protein of the HIV to a length of one or more corresponding variable regions of an envelope protein of the reference HIV or a number of glycosylation sites on the envelope protein of the reference HIV, wherein the HIV is likely to be more resistant to the CD4 binding site entry inhibitor than the reference HIV when the HIV has longer variable regions than the reference HIV or the HIV has more glycosylation sites than the reference HIV.
摘要翻译：本发明提供了一种用于确定人类免疫缺陷病毒是否比参照HIV更可能对病毒进入抑制剂更具抗性的方法。在某些方面，所述方法包括将HIV的包膜蛋白的一个或多个可变区的长度或HIV的包膜蛋白上的多个糖基化位点的长度与包膜蛋白的一个或多个相应可变区的长度进行比较参考HIV或参考HIV的包膜蛋白上的多个糖基化位点，其中当艾滋病毒具有比参考HIV更长的可变区时，HIV比参照HIV更可耐CD4结合位点进入抑制剂或者HIV比参考HIV具有更多的糖基化位点。

5. 发明申请

WO2004079930A3 ASYNCHRONOUS MECHANISM AND MESSAGE POOL 审中-公开
标题翻译：不同寻常的机制和消息池
公开(公告)号：WO2004079930A3
公开(公告)日：2005-05-06
申请号：PCT/US2004006887
申请日：2004-03-04
申请人： MESSAGESOFT INC , JIANG JIANGUO , LIU YAPING , LIANG JINGWEI , HUANG WEI , WU SHIJUN
发明人： JIANG JIANGUO , LIU YAPING , LIANG JINGWEI , HUANG WEI , WU SHIJUN
IPC分类号： G06F15/16 , H04B20060101 , H04L12/56 , H04L12/58
CPC分类号： H04L51/26 , G06F9/546 , H04L47/2441 , H04L47/50 , H04L47/521 , H04L47/6215 , H04L49/90 , H04L49/9036 , H04L51/14 , H04L51/30
摘要： Messages are received and retained in memory and are batch processed including transferring the messages to a cell pool having cells of predetermined size. The location and size of the messages are recorded in a table map with other pertinent information as is required. Messages in the cell pool are processed and delivered asynchronously.
摘要翻译：消息被接收并保留在存储器中并被批处理，包括将消息传送到具有预定大小的小区的小区池。消息的位置和大小记录在表格映射中，并且需要其他相关信息。单元池中的消息将被异步处理和传送。

6. 发明申请

WO2013192526A3 USE OF OXYGEN FROM ION TRANSPORT MEMBRANES IN BLAST FURNACE 审中-公开
标题翻译：在离子交换膜中使用氧气
公开(公告)号：WO2013192526A3
公开(公告)日：2014-02-27
申请号：PCT/US2013047062
申请日：2013-06-21
申请人： AIR LIQUIDE , GROVER BHADRA S , KAISER KENNETH , GRANT MICHAEL G K , HUANG WEI
发明人： GROVER BHADRA S , KAISER KENNETH , GRANT MICHAEL G K , HUANG WEI
IPC分类号： C21B5/00 , B01D53/22 , C01B13/02 , C21B9/00
CPC分类号： B01D53/22 , B01D2256/12 , C01B13/0255 , C21B5/00 , C21B9/00 , C21B2100/66
摘要： The present invention is a method of integrating oxygen production with blast furnace operation. A heated air stream is introduced to an ion transfer membrane separator, producing a permeate and a retentate. The permeate and the motive stream are introduced into an ejector jet pump producing an oxygen enriched stream. The oxygen enriched stream is introduced into blast furnace. In another embodiment of the present invention, the permeate and a steam motive stream are introduced into an ejector jet pump. Heated air inlet stream is introduced into a cascading series of ion transfer membrane separators, producing a series of permeate streams and a series of retentate streams wherein each retentate stream acts as the input stream for the subsequent ion transfer membrane separator. Thereby producing a series of oxygen enriched streams which are combined and introduced into blast furnace.
摘要翻译：本发明是一种将氧气生产与高炉操作相结合的方法。将加热的空气流引入离子转移膜分离器，产生渗透物和渗余物。将渗透物和动力流引入产生富氧物流的喷射喷射泵中。将富氧物流引入高炉。在本发明的另一个实施例中，将渗透物和蒸气动力流引入喷射器喷射泵中。加热空气入口流被引入到级联系列的离子转移膜分离器中，产生一系列渗透物流和一系列滞留物流，其中每个滞留物流用作后续离子转移膜分离器的输入流。从而产生一系列富集的物流，其被组合并引入高炉。

7. 发明申请

WO2010102042A3 BALANCED METAMATERIAL ANTENNA DEVICE 审中-公开
标题翻译：平衡金属天线装置
公开(公告)号：WO2010102042A3
公开(公告)日：2011-01-13
申请号：PCT/US2010026099
申请日：2010-03-03
申请人： RAYSPAN CORP , HUANG WEI , PENEV VLADIMIR , PATHAK VANEET , POILASNE GREGORY
发明人： HUANG WEI , PENEV VLADIMIR , PATHAK VANEET , POILASNE GREGORY
IPC分类号： H01Q1/38 , H01Q9/04
CPC分类号： H01Q9/16 , H01Q15/0086
摘要： This document describes designs and techniques for directly feeding an unbalanced transmission line with a balanced antenna using Composite Right and Left Handed (CRLH) and balun structures.
摘要翻译：本文件描述了使用复合右手和左手（CRLH）和平衡 - 不平衡变换器直接馈送具有平衡天线的不平衡传输线的设计和技术。

8. 发明申请

WO2008056144A3 METHODS FOR DETECTING TOLUENE AND XYLENE USING AS BIOSENSOR A TRANFORMED ACINETOBACTER BAYLYI ADP1 审中-公开
标题翻译：使用生化传感器检测甲苯和二甲苯的方法一种经过改进的ACINETOBACTER BAYLYI ADP1
公开(公告)号：WO2008056144A3
公开(公告)日：2008-08-07
申请号：PCT/GB2007004254
申请日：2007-11-07
申请人： NATURAL ENVIRONMENT RES , HUANG WEI , WHITELEY ANDREW
发明人： HUANG WEI , WHITELEY ANDREW
IPC分类号： C12N15/09
CPC分类号： C12N15/1051 , C12Q1/6897
摘要： The present invention relates to novel methods for producing a biosensor for detecting a specific compound, for identifying a gene encoding a regulatory protein responsive to a specific compound and for identifying a gene encoding a regulatory protein responsive to a specific compound.
摘要翻译：本发明涉及生产用于检测特定化合物的生物传感器的新方法，用于鉴定编码对特定化合物有响应的调节蛋白的基因，并鉴定编码对特定化合物有响应的调节蛋白的基因。

9. 发明申请

WO2006099128A2 METHOD AND APPARATUS FOR CWDM OPTICAL TRANSMITTER WITH EXTENDED OPERATING TEMPERATURE RANGE 审中-公开
标题翻译：具有延长工作温度范围的CWDM光学发射器的方法和装置
公开(公告)号：WO2006099128A2
公开(公告)日：2006-09-21
申请号：PCT/US2006008583
申请日：2006-03-10
申请人： HARMONIC INC , BONEN ADI , NGUYEN HOA , CHEN LIPING , HUANG WEI
发明人： BONEN ADI , NGUYEN HOA , CHEN LIPING , HUANG WEI
CPC分类号： H01S5/02453 , H01S5/02415
摘要： An optical transmitter for coarse wavelength division multiplexed (CWDM) optical communication systems uses a conventional laser (e.g. laser diode) and in addition a heater element is provided thermally coupled to the laser. A thermal sensor and associated control circuit drive the heater so as to control the power consumed by the heater to assure that the laser's temperature is not lower than a predetermined minimum working temperature. When the sensed laser temperature is above this predetermined minimum temperature, the control circuit turns off the heater. The total operating range of the transmitter in terms of ambient temperature is thus extended beyond its inherent operating range by the maximum laser temperature rise created by the heater. This allows a CWDM optical transmitter with the heater and control circuitry to be used in outdoor applications where a wide ambient temperature range is required.
摘要翻译：用于粗波分复用（CWDM）光通信系统的光发射机使用常规激光器（例如激光二极管），此外，加热元件被热耦合到激光器。热传感器和相关控制电路驱动加热器，以便控制加热器消耗的功率，以确保激光器的温度不低于预定的最低工作温度。当感测的激光温度高于该预定的最低温度时，控制电路关闭加热器。因此，通过由加热器产生的最大激光温度上升，传感器在环境温度方面的总工作范围因此延伸到其固有的工作范围之外。这允许具有加热器和控制电路的CWDM光发射机用于需要宽环境温度范围的户外应用中。

10. 发明申请

WO0242272A8 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDINES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE 审中-公开
标题翻译：用于选择性抑制凝聚剂CASCADE的取代的多环芳烃和异丁基吡啶
公开(公告)号：WO0242272A8
公开(公告)日：2003-10-23
申请号：PCT/US0143280
申请日：2001-11-20
申请人： PHARMACIA CORP , SOUTH MICHAEL S , CASE BRENDA , GARLAND DANNY J , HAYES MICHAEL J , HUANG HORNG-CHIH , HUANG WEI , JONES DARIN E , NEUMANN WILLIAM L , PARLOW JOHN J , REITZ DAVID B , RUEPPEL MELVIN L , WEBBER RONALD K
发明人： SOUTH MICHAEL S , CASE BRENDA , GARLAND DANNY J , HAYES MICHAEL J , HUANG HORNG-CHIH , HUANG WEI , JONES DARIN E , NEUMANN WILLIAM L , PARLOW JOHN J , REITZ DAVID B , RUEPPEL MELVIN L , WEBBER RONALD K
IPC分类号： A61K31/44 , A61K31/4418 , A61K31/4436 , A61K31/4439 , A61K45/00 , A61P7/02 , A61P9/10 , A61P11/00 , A61P35/00 , A61P43/00 , C07D213/74 , C07D213/89 , C07D401/10 , C07D409/04 , C07D213/77 , C07D213/90 , C07D237/20 , C07D239/36 , C07D239/42 , C07D241/20 , C07D253/04 , C07D253/06 , C07D265/02 , C07D417/12
CPC分类号： C07D213/74 , C07D213/89
摘要： The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.
摘要翻译：本发明涉及化合物及其前药，可用于预防和治疗哺乳动物血栓形成病症的组合物和方法。本发明的化合物及其前药选择性地抑制凝血级联的某些蛋白酶。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式